TickerFacts.

A business in context

DVA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-22 · 0000927066-26-000126

  2. 4 · Ownership change

    Report date 2026-08-15 · 0000927066-26-000124

  3. 4 · Ownership change

    Report date 2026-08-15 · 0000927066-26-000123

  4. 4 · Ownership change

    Report date 2026-08-15 · 0000927066-26-000122

  5. 4 · Ownership change

    Report date 2026-08-15 · 0000927066-26-000121

  6. 4 · Ownership change

    Report date 2026-08-15 · 0000927066-26-000120

  7. 4 · Ownership change

    Report date 2026-08-15 · 0000927066-26-000119

  8. 4 · Ownership change

    Report date 2026-08-15 · 0000927066-26-000118

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000927066-26-000108

  10. 8-K · Current report

    Report date 2026-08-04 · 0000927066-26-000105 · Items 2.02,9.01

  11. 8-K · Current report

    Report date 2026-06-04 · 0001206774-26-000316 · Items 1.01,2.03,5.07,9.01

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000927066-26-000062

  13. 8-K · Current report

    Report date 2026-05-05 · 0000927066-26-000060 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0000927066-26-000053

  15. 10-K · Annual report

    Report date 2025-12-31 · 0000927066-26-000012

  16. 8-K · Current report

    Report date 2026-02-02 · 0000927066-26-000004 · Items 2.02,9.01

  17. 8-K · Current report

    Report date 2025-11-24 · 0001206774-25-000750 · Items 1.01,2.03,9.01

  18. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000927066-25-000165

  19. 8-K · Current report

    Report date 2025-10-29 · 0000927066-25-000163 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2025-08-20 · 0000927066-25-000154 · Items 8.01

  21. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000927066-25-000124

  22. 8-K · Current report

    Report date 2025-08-05 · 0000927066-25-000122 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-07-17 · 0001193125-25-160501 · Items 1.01,2.03,9.01

  24. 8-K · Current report

    Report date 2025-06-05 · 0000927066-25-000107 · Items 5.07

  25. 8-K · Current report

    Report date 2025-05-23 · 0001206774-25-000378 · Items 1.01,2.03,9.01

  26. 8-K · Current report

    Report date 2025-05-20 · 0001206774-25-000369 · Items 8.01,9.01

  27. 8-K · Current report

    Report date 2025-05-20 · 0001206774-25-000368 · Items 8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000927066-25-000087

  29. 8-K · Current report

    Report date 2025-05-12 · 0000927066-25-000085 · Items 2.02,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-06-05 · 0000927066-25-000076

  31. 8-K · Current report

    Report date 2025-04-12 · 0001193125-25-079593 · Items 8.01

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000927066-25-000012

  33. 8-K · Current report

    Report date 2025-02-13 · 0000927066-25-000009 · Items 2.02,9.01

  34. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000927066-24-000179

  35. 8-K · Current report

    Report date 2024-10-29 · 0000927066-24-000177 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2024-09-09 · 0001206774-24-000897 · Items 5.02,9.01

  37. 8-K · Current report

    Report date 2024-09-05 · 0000927066-24-000162 · Items 5.03,8.01,9.01

  38. 8-K · Current report

    Report date 2024-08-13 · 0001206774-24-000784 · Items 1.01,2.03,9.01

  39. 8-K · Current report

    Report date 2024-08-08 · 0001206774-24-000776 · Items 8.01,9.01

  40. 8-K · Current report

    Report date 2024-08-08 · 0001206774-24-000769 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 8 transaction rows8AExercise / conversion: 0 transaction rows0MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

10 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-22
2026-09-24
Maughan David PaulF · Tax / exercise payment
Disposed
Common Stock7501.0182.34
2026-08-15
2026-08-18
Hollar Jason M.A · Grant / award
Acquired
Common Stock278.00.0
2026-08-15
2026-08-18
DESOER BARBARA JA · Grant / award
Acquired
Common Stock278.00.0
2026-08-15
2026-08-18
Schechter Adam HA · Grant / award
Acquired
Common Stock278.00.0
2026-08-15
2026-08-18
Moore Gregory J.A · Grant / award
Acquired
Common Stock278.00.0
2026-08-15
2026-08-18
Pullin Dennis WA · Grant / award
Acquired
Common Stock278.00.0
2026-08-15
2026-08-18
Schoppert Wendy LeeA · Grant / award
Acquired
Common Stock278.00.0
2026-08-15
2026-08-18
Arway Pamela MA · Grant / award
Acquired
Common Stock278.00.0
2026-08-15
2026-08-18
YALE PHYLLIS RA · Grant / award
Acquired
Common Stock278.00.0
2026-07-31
2026-08-04
BERKSHIRE HATHAWAY INC; BUFFETT WARREN ES · Sale
Disposed
Common Stock182980.0199.55

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000927066DAVITA INC.
DaVita Medical Group

Showing 1 of 1 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
M2XHYMU3TZNEZURC6H66
GLEIF legal name
DAVITA INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-10-20T08:09:22Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • DaVita · alias · wikidata
  • DaVita Kidney Care · alias · wikidata
  • DaVita Dialysis · alias · wikidata
  • DaVita Medical Group · subsidiary · wikidata
  • DAVITA HEALTHCARE PARTNERS INC. · former SEC name · 2012-08-02 to 2016-08-12
  • DAVITA INC · former SEC name · 2000-11-17 to 2012-11-02
  • TOTAL RENAL CARE HOLDINGS INC · former SEC name · 1996-08-14 to 2000-01-28
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$12.82B$13.77B
2023-12-31$12.14B$13.42B
2022-12-31$11.61B$13.36B
2021-12-31$11.62B$14.45B
2020-12-31$11.55B$15.04B
2019-12-31$11.39B$15.01B
2018-12-31$11.40B$15.30B
2017-12-31$10.88B$14.95B

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗